SCHEMBL4285483

SCHEMBL4285483

CCCCn1c(-c2c[nH]nc2Cc2cccc(F)c2)nc2c1c(=O)[nH]c(=O)n2C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
KDM1A O60341 2/20 0.54
ALDH1A1 P00352 8/20 0.50
KDM4E B2RXH2 5/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ABL1 P00519 2/20 0.49
LCK P06239 2/20 0.49
YES1 P07947 2/20 0.49
SRC P12931 2/20 0.49
EPHB4 P54760 2/20 0.49
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TNF P01375 1/20 0.46
NOD2 Q9HC29 1/20 0.46
LMNA P02545 2/20 0.46
TSHR P16473 3/20 0.45
CXCL8 P10145 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4291739 0.95 KDM1A (0.60) MEN1KMT2AKDM1AALDH1A1KDM4E
SCHEMBL4284310 0.92 KDM1A (0.54) MEN1KMT2AKDM1AALDH1A1KDM4E
SCHEMBL4016883 0.80 TPH1 (0.44) MEN1KMT2AKDM1AALDH1A1KDM4E
SCHEMBL2327640 0.78 ADORA2B (0.62) MEN1KMT2AKDM1AALDH1A1KDM4E
SCHEMBL4019166 0.78 NOD1 (0.37) MEN1KMT2AKDM1ANOD1
SCHEMBL4018480 0.77 TPH1 (0.50) MEN1KMT2AKDM1AALDH1A1KDM4E
SCHEMBL5509419 0.77 ADORA3 (0.44) MEN1KMT2AKDM1AALDH1A1KDM4E
SCHEMBL4016181 0.73 MEN1 (0.42) MEN1KMT2AKDM1AALDH1A1HTT
SCHEMBL5687959 0.71 ADORA2B (0.63) MEN1KMT2AALDH1A1KDM4EHSD17B10
SCHEMBL4014400 0.71 ADORA2A (0.41) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009157938-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING CANCER CV THERAPEUTICS, INC. (US) 2009-12-30 WO disclosed